Literature DB >> 20652507

Introduction to epigenomics and epigenome-wide analysis.

Melissa J Fazzari1, John M Greally.   

Abstract

Epigenetics is the study of heritable change other than those encoded in DNA sequence. Cytosine methylation of DNA at CpG dinucleotides is the most well-studied epigenetic phenomenon, although epigenetic changes also encompass non-DNA methylation mechanisms, such as covalent histone modifications, micro-RNA interactions, and chromatin remodeling complexes. Methylation changes, both global and gene specific, have been observed to be associated with disease, particularly in cancer.This chapter begins with a general overview of epigenomics, and then focuses on understanding and analyzing genome-wide cytosine methylation data. There are many microarray-based techniques available to measure cytosine methylation across the genome, as well as gold-standard techniques based on sequencing bisulfite converted DNA, which is used to measure methylation in a smaller, more targeted set of loci. We have provided an overview of many of the current technologies - their advantages, limitations, and recent improvements. Regardless of which technology is used, the goal is to produce a set of methylation measurements that are highly consistent with true methylation levels of the corresponding set of CpG dinucleotides.Identifying all loci with aberrant methylation or hypomethylation in disease, or in natural processes such as aging, requires the comparison of methylation levels across many samples. In such studies, the development of methylation-based diagnostic tools may be of interest, potentially to be used as early disease detection strategies based on a set of sentinel loci. In addition, the identification of loci with potentially reversible methylation events may result in new therapeutic options. Given the vast number of measurable sites, prioritization of candidate loci is an important and complex issue and rests on a foundation of appropriate statistical testing and summarization. Coupled with statistical estimates of importance, the genomic context of each locus measured may offer important information about the mechanisms by which epigenetic changes impact disease and allows us further refinement of candidate loci. We will conclude this chapter by identifying issues in building methylation-based models for prediction and potential directions of further statistical research in epigenetics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20652507     DOI: 10.1007/978-1-60761-580-4_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  26 in total

Review 1.  Using DNA methylation to understand biological consequences of genetic variability.

Authors:  Dena G Hernandez; Andrew B Singleton
Journal:  Neurodegener Dis       Date:  2011-11-26       Impact factor: 2.977

Review 2.  Targeting the epigenome with bioactive food components for cancer prevention.

Authors:  Thomas Prates Ong; Fernando Salvador Moreno; Sharon Ann Ross
Journal:  J Nutrigenet Nutrigenomics       Date:  2012-02-22

Review 3.  Epigenetic biomarkers in skin cancer.

Authors:  Edward S Greenberg; Kelly K Chong; Kelly T Huynh; Ryo Tanaka; Dave S B Hoon
Journal:  Cancer Lett       Date:  2012-01-27       Impact factor: 8.679

Review 4.  Epigenetic cancer prevention mechanisms in skin cancer.

Authors:  Kamalika Saha; Thomas J Hornyak; Richard L Eckert
Journal:  AAPS J       Date:  2013-08-01       Impact factor: 4.009

5.  Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells.

Authors:  Luciano Pirola; Aneta Balcerczyk; Richard W Tothill; Izhak Haviv; Antony Kaspi; Sebastian Lunke; Mark Ziemann; Tom Karagiannis; Stephen Tonna; Adam Kowalczyk; Bryan Beresford-Smith; Geoff Macintyre; Ma Kelong; Zhang Hongyu; Jingde Zhu; Assam El-Osta
Journal:  Genome Res       Date:  2011-09-02       Impact factor: 9.043

Review 6.  Genome-scale techniques highlight the epigenome and redefine fundamental principles of gene regulation.

Authors:  J Wesley Pike
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

7.  Precision Physical Therapy: Exercise, the Epigenome, and the Heritability of Environmentally Modified Traits.

Authors:  Jessica R Woelfel; Shauna Dudley-Javoroski; Richard K Shields
Journal:  Phys Ther       Date:  2018-11-01

Review 8.  Prenatal environmental exposures, epigenetics, and disease.

Authors:  Frederica Perera; Julie Herbstman
Journal:  Reprod Toxicol       Date:  2011-01-20       Impact factor: 3.143

Review 9.  Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.

Authors:  Mukesh Verma; Muin J Khoury; John P A Ioannidis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-14       Impact factor: 4.254

Review 10.  The fate is not always written in the genes: epigenomics in epidemiologic studies.

Authors:  Scott M Langevin; Karl T Kelsey
Journal:  Environ Mol Mutagen       Date:  2013-02-26       Impact factor: 3.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.